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A 37-year-old lady was referred to rheumatology (Treliske Hospital, Truro) in 2015 following 8 months of rib pain, initially thought to be costochondritis. She had isolated hypophosphataemia (0.50mmol/L) and a pelvic MRI identified stress fractures (Figure 1a ). 14 months after her presentation she had a persistent low phosphate, with normal PTH,serum calcium and 25(OH)vitamin D of 32ng/mL. It was concluded that "she has subclinical [vitamin D] deficiency" and she was administered cholecalciferol 20,000 units/week and SandoPhos, 2 tablets BD. In March 2016, still symptomatic, she was referred to the UCL Centre for Nephrology to investigate a possible renal cause for the hypophosphataemia.
There, her calculated urinary fractional excretion of phosphate was raised at 42%, confirming hyperphosphaturia. Her gender and age weighed against X-linked, autosomal dominant, or recessive hypophosphtaemic rickets; normal excretion of low molecular weight protein, urate and glucose ruled out the renal Fanconi syndrome. The serum concentration of FGF23 was 180RU/ml (NR 0-150). Previous standard practice protocolled a first-line FDG PET/CT scan, which identified a nasal cavity mass which was avid on a subsequent 68 Ga DOTATATE PET/CT (Figure 1b The only definitive management is removal of the phosphaturic mesenchymal tumour; recurrence is rare but has been described.
